DK2327407T3 - Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme - Google Patents

Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme

Info

Publication number
DK2327407T3
DK2327407T3 DK09816166.4T DK09816166T DK2327407T3 DK 2327407 T3 DK2327407 T3 DK 2327407T3 DK 09816166 T DK09816166 T DK 09816166T DK 2327407 T3 DK2327407 T3 DK 2327407T3
Authority
DK
Denmark
Prior art keywords
prophylactic
therapeutic agent
gastrointestinal diseases
functional gastrointestinal
functional
Prior art date
Application number
DK09816166.4T
Other languages
English (en)
Inventor
Satoru Tamaoki
Jun Sato
Katsuichi Sudo
Original Assignee
Aska Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aska Pharm Co Ltd filed Critical Aska Pharm Co Ltd
Application granted granted Critical
Publication of DK2327407T3 publication Critical patent/DK2327407T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK09816166.4T 2008-09-26 2009-09-24 Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme DK2327407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008248932 2008-09-26
PCT/JP2009/066533 WO2010035751A1 (ja) 2008-09-26 2009-09-24 機能性消化管障害の予防及び/又は治療剤

Publications (1)

Publication Number Publication Date
DK2327407T3 true DK2327407T3 (da) 2014-08-25

Family

ID=42059749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09816166.4T DK2327407T3 (da) 2008-09-26 2009-09-24 Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme

Country Status (14)

Country Link
US (1) US8980872B2 (da)
EP (1) EP2327407B1 (da)
JP (1) JP5567484B2 (da)
KR (1) KR20110071096A (da)
CN (1) CN102164599B (da)
AU (1) AU2009297562B2 (da)
BR (1) BRPI0918997A2 (da)
CA (1) CA2736285C (da)
DK (1) DK2327407T3 (da)
ES (1) ES2496190T3 (da)
PL (1) PL2327407T3 (da)
PT (1) PT2327407E (da)
RU (1) RU2011116400A (da)
WO (1) WO2010035751A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
EP2493471B1 (en) 2009-10-26 2019-11-27 Thomas Julius Borody Novel enteric combination therapy
CN114366759A (zh) * 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20190298783A1 (en) 2018-03-28 2019-10-03 Morinaga Milk Industry Co., Ltd. Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
JPS6123192A (ja) 1984-07-11 1986-01-31 三菱電機株式会社 マトリクス型表示装置の製造方法
IT1253711B (it) 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
IT1264494B1 (it) 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
IT1290679B1 (it) 1997-02-14 1998-12-10 Alfa Wassermann Spa Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
MX2008011305A (es) 2006-03-09 2009-02-10 Salix Pharmaceuticals Inc Preparacion anti-disfunsion rectal con rifaximina.
MX2009001342A (es) * 2006-08-02 2009-08-31 Salix Pharmaceuticals Inc Composiciones y metodos para el tratamiento de proctosigmoiditis por radiacion.

Also Published As

Publication number Publication date
EP2327407A1 (en) 2011-06-01
RU2011116400A (ru) 2012-11-10
PL2327407T3 (pl) 2014-12-31
CN102164599A (zh) 2011-08-24
KR20110071096A (ko) 2011-06-28
PT2327407E (pt) 2014-09-10
CA2736285C (en) 2016-08-23
JPWO2010035751A1 (ja) 2012-02-23
WO2010035751A1 (ja) 2010-04-01
EP2327407A4 (en) 2012-02-29
BRPI0918997A2 (pt) 2015-12-01
US8980872B2 (en) 2015-03-17
CA2736285A1 (en) 2010-04-01
EP2327407B1 (en) 2014-07-09
ES2496190T3 (es) 2014-09-18
AU2009297562A1 (en) 2010-04-01
AU2009297562B2 (en) 2015-04-23
JP5567484B2 (ja) 2014-08-06
US20110152517A1 (en) 2011-06-23
CN102164599B (zh) 2014-07-23

Similar Documents

Publication Publication Date Title
HUS2100009I1 (hu) Halauxifen-metil és piroxszulam kombinációja
NO2017002I2 (no) Kobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2437762T3 (da) Kunstige tårer og terapeutiske anvendelser
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK3351558T3 (da) Materiale og fremgangsmåder til behandling eller forebyggelse af her-3-relaterede sygdomme
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2304568T3 (da) Fremgangsmåde og system til fordelt raid-implementering
DK2273975T3 (da) Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser
EP2300094A4 (en) INFLATABLE MEDICINE PRODUCTS
DK2405869T3 (da) Fedmebehandling
DK2337837T3 (da) Alpha-amylase-blandinger og fremgangsmåder til anvendelse heraf
DK2479174T3 (da) 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf
DK3092901T3 (da) Quinolonanaloger og fremgangsmåder relateret dertil
DK3560915T3 (da) Polypeptider med oxidoreduktaseaktivitet og anvendelser deraf
EP2241332A4 (en) THERAPEUTIC AGENT AGAINST PRITURE
DK2192933T3 (da) Materialer til oftalmologisk og ortorhinolaryngologisk anordning
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2288643T3 (da) Skumpolyestere og fremgangsmåder til fremstilling heraf
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
NO20084074L (no) Fremgangsmåte og system for behandling av gass
EP2471546A4 (en) THERAPEUTIC ACTIVE AGAINST RHINITIS
HUE037105T2 (hu) Eljárások és készítmények tumorok megsemmisítésére